ACT for ME/CFS - an Open Case Trial

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 10, 2012

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Chronic Fatigue Syndrome
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy (ACT)

The main target in ACT for ME/CFS (as for Fibromyalgia and Chronic pain in previous studies by our group) is to promote a shift of perspective in life from symptom reduction (when it does not work) to a valued life. As such it entails acceptance and exposure to discomfort, in order to lessen the effects of negative experiences (symptoms, emotions, thoughts) on behaviours in everyday life.

Trial Locations (1)

171 77

Karolinska Institutet, Stockholm

All Listed Sponsors
collaborator

Region Stockholm

OTHER_GOV

collaborator

Skandia Insurance Company, Ltd.

UNKNOWN

lead

Rikard Wicksell

OTHER

NCT03562325 - ACT for ME/CFS - an Open Case Trial | Biotech Hunter | Biotech Hunter